What we learn about bipolar disorder from large-scale neuroimaging: Findings and future directions from the ENIGMA Bipolar Disorder Working Group.

ENIGMA MRI bipolar disorder cortical surface area cortical thickness mega-analysis meta-analysis neuroimaging psychiatry volume

Journal

Human brain mapping
ISSN: 1097-0193
Titre abrégé: Hum Brain Mapp
Pays: United States
ID NLM: 9419065

Informations de publication

Date de publication:
01 2022
Historique:
revised: 31 05 2020
received: 31 03 2020
accepted: 04 06 2020
pubmed: 30 7 2020
medline: 29 3 2022
entrez: 30 7 2020
Statut: ppublish

Résumé

MRI-derived brain measures offer a link between genes, the environment and behavior and have been widely studied in bipolar disorder (BD). However, many neuroimaging studies of BD have been underpowered, leading to varied results and uncertainty regarding effects. The Enhancing Neuro Imaging Genetics through Meta-Analysis (ENIGMA) Bipolar Disorder Working Group was formed in 2012 to empower discoveries, generate consensus findings and inform future hypothesis-driven studies of BD. Through this effort, over 150 researchers from 20 countries and 55 institutions pool data and resources to produce the largest neuroimaging studies of BD ever conducted. The ENIGMA Bipolar Disorder Working Group applies standardized processing and analysis techniques to empower large-scale meta- and mega-analyses of multimodal brain MRI and improve the replicability of studies relating brain variation to clinical and genetic data. Initial BD Working Group studies reveal widespread patterns of lower cortical thickness, subcortical volume and disrupted white matter integrity associated with BD. Findings also include mapping brain alterations of common medications like lithium, symptom patterns and clinical risk profiles and have provided further insights into the pathophysiological mechanisms of BD. Here we discuss key findings from the BD working group, its ongoing projects and future directions for large-scale, collaborative studies of mental illness.

Identifiants

pubmed: 32725849
doi: 10.1002/hbm.25098
pmc: PMC8675426
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, N.I.H., Intramural Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

56-82

Subventions

Organisme : NIMH NIH HHS
ID : T32 MH073526
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001863
Pays : United States
Organisme : CIHR
ID : 142255
Pays : Canada
Organisme : NIA NIH HHS
ID : T32 AG058507
Pays : United States
Organisme : NIBIB NIH HHS
ID : U54 EB020403
Pays : United States
Organisme : NIMH NIH HHS
ID : R21 MH113871
Pays : United States
Organisme : NIMH NIH HHS
ID : R37 MH100041
Pays : United States
Organisme : NIMH NIH HHS
ID : K23 MH085096
Pays : United States
Organisme : Medical Research Council
ID : MC_PC_17209
Pays : United Kingdom
Organisme : NIMH NIH HHS
ID : R01 MH080912
Pays : United States
Organisme : NIMH NIH HHS
ID : K23 MH074644
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH100041
Pays : United States
Organisme : NIGMS NIH HHS
ID : P20 GM121312
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH096957
Pays : United States
Organisme : Wellcome Trust
ID : 104036/Z/14/Z
Pays : United Kingdom
Organisme : NIMH NIH HHS
ID : R01 MH060952
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH083968
Pays : United States
Organisme : NIMH NIH HHS
ID : K23 MH098130
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH059929
Pays : United States
Organisme : Medical Research Council
ID : MR/L010305/1
Pays : United Kingdom
Organisme : NIMH NIH HHS
ID : R01 MH095454
Pays : United States
Organisme : Department of Health
Pays : United Kingdom
Organisme : NIMH NIH HHS
ID : K08 MH086786
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH116147
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH101111
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH106324
Pays : United States
Organisme : NIA NIH HHS
ID : R56 AG058854
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH075007
Pays : United States
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 216767/Z/19/Z
Pays : United Kingdom
Organisme : NIMH NIH HHS
ID : R03 MH105808
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH107703
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH085667
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH090553
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH076971
Pays : United States

Informations de copyright

© 2020 The Authors. Human Brain Mapping published by Wiley Periodicals LLC.

Références

Mol Psychiatry. 2021 Aug;26(8):4315-4330
pubmed: 31857689
Br J Psychiatry. 1973 Jan;122(566):15-30
pubmed: 4683020
Front Psychiatry. 2018 Nov 29;9:641
pubmed: 30555363
Hum Brain Mapp. 2017 Sep;38(9):4444-4458
pubmed: 28580697
Schizophr Bull. 2007 May;33(3):703-14
pubmed: 17478437
Alzheimers Dement. 2018 Apr;14(4):535-562
pubmed: 29653606
J Affect Disord. 2009 Jun;115(3):395-410
pubmed: 19019455
Cereb Cortex. 2019 Jul 22;29(8):3351-3362
pubmed: 30169567
Biol Psychiatry. 2018 Feb 1;83(3):244-253
pubmed: 29217296
Psychol Med. 2020 Dec;50(16):2682-2690
pubmed: 31615595
Psychiatry Clin Neurosci. 2019 Jul;73(7):357-369
pubmed: 30864184
J Clin Psychiatry. 2009 Apr 21;70(5):699-705
pubmed: 19389332
Lancet. 1976 Oct 30;2(7992):924-6
pubmed: 62160
Brain. 2015 Nov;138(Pt 11):3440-8
pubmed: 26373602
Nature. 2020 Jun;582(7810):84-88
pubmed: 32483374
Am J Psychiatry. 2016 Sep 9;174(1):60-69
pubmed: 27609241
Science. 2018 Jun 22;360(6395):
pubmed: 29930110
Neuroimage. 2006 May 1;30(4):1414-32
pubmed: 16413796
Clin Pharmacol Ther. 2001 Mar;69(3):89-95
pubmed: 11240971
Nat Rev Neurosci. 2013 May;14(5):365-76
pubmed: 23571845
Prog Neuropsychopharmacol Biol Psychiatry. 2020 Mar 2;98:109817
pubmed: 31756418
Science. 2020 Mar 20;367(6484):
pubmed: 32193296
Neuroimage. 2010 Apr 15;50(3):1148-67
pubmed: 20056149
JAMA. 2017 Mar 14;317(10):1019-1020
pubmed: 28192565
Arch Gen Psychiatry. 2011 Aug;68(8):773-80
pubmed: 21464342
Mol Psychiatry. 2018 Apr;23(4):932-942
pubmed: 28461699
Neuron. 2017 Apr 19;94(2):232-236
pubmed: 28426957
Mol Psychiatry. 2020 Sep;25(9):2130-2143
pubmed: 30171211
Nat Neurosci. 2016 Nov;19(11):1523-1536
pubmed: 27643430
Biol Psychiatry. 2019 Oct 1;86(7):545-556
pubmed: 31443932
Mol Psychiatry. 2017 Jun;22(6):900-909
pubmed: 27137745
Annu Rev Clin Psychol. 2013;9:91-121
pubmed: 23537483
Transl Psychiatry. 2017 Jan 10;7(1):e993
pubmed: 28072414
Am J Psychiatry. 2019 Jul 1;176(7):531-542
pubmed: 31014101
Can J Psychiatry. 2009 Feb;54(2):105-12
pubmed: 19254441
Biol Psychiatry. 2013 Jan 15;73(2):144-52
pubmed: 22818781
Lancet Psychiatry. 2017 Apr;4(4):310-319
pubmed: 28219628
J Psychiatry Neurosci. 2012 Sep;37(5):333-43
pubmed: 22498078
J Affect Disord. 2016 Feb;191:8-14
pubmed: 26599364
Mol Psychiatry. 2016 Apr;21(4):585
pubmed: 26283641
Nat Genet. 2018 May;50(5):668-681
pubmed: 29700475
Bipolar Disord. 2012 Nov;14(7):764-79
pubmed: 23036083
Hum Brain Mapp. 2007 Jun;28(6):488-501
pubmed: 17440953
Epidemiology. 2008 Sep;19(5):640-8
pubmed: 18633328
Neurosci Biobehav Rev. 2010 Mar;34(4):533-54
pubmed: 19896972
Hum Brain Mapp. 2022 Jan;43(1):56-82
pubmed: 32725849
Bipolar Disord. 2019 Nov;21(7):582-594
pubmed: 31465619
Nature. 2014 Jul 24;511(7510):421-7
pubmed: 25056061
Brain Imaging Behav. 2014 Jun;8(2):153-82
pubmed: 24399358
Curr Opin Psychiatry. 2016 Jan;29(1):1-6
pubmed: 26575297
Biol Psychiatry. 2014 Aug 1;76(3):239-48
pubmed: 24199669
Psychiatry Clin Neurosci. 2020 Mar;74(3):220-221
pubmed: 31858667
Eur Neuropsychopharmacol. 2016 Nov;26(11):1741-1751
pubmed: 27665062
Mol Psychiatry. 2020 Jul;25(7):1511-1525
pubmed: 31471575
Schizophr Bull. 2007 Jul;33(4):893-904
pubmed: 17562698
Nature. 2012 Sep 20;489(7416):391-399
pubmed: 22996553
Prog Neuropsychopharmacol Biol Psychiatry. 2019 Apr 20;91:20-27
pubmed: 29601896
Neuroimage. 2006 Jul 15;31(4):1487-505
pubmed: 16624579
Neurosci Res. 2016 Jan;102:4-12
pubmed: 26051908
Neuroimage. 2010 Nov 15;53(3):804-9
pubmed: 20080192
Science. 2018 Feb 9;359(6376):693-697
pubmed: 29439242
Mol Psychiatry. 2018 May;23(5):1261-1269
pubmed: 29038599
Int J Bipolar Disord. 2017 Nov 22;5(1):37
pubmed: 29164495
Ann Neurosci. 2016 Mar;23(1):3-5
pubmed: 27536015
Eur Neuropsychopharmacol. 2015 Feb;25(2):158-68
pubmed: 25261263
Am J Psychiatry. 2018 May 1;175(5):453-462
pubmed: 29377733
Nat Genet. 2019 Nov;51(11):1624-1636
pubmed: 31636452
Biol Psychiatry. 2013 Dec 15;74(12):908-16
pubmed: 23684382
Nat Commun. 2017 Jan 18;8:13624
pubmed: 28098162
Cereb Cortex. 2018 Sep 1;28(9):3267-3277
pubmed: 28968835
Schizophr Res. 2004 Dec 1;71(2-3):405-16
pubmed: 15474912
Nat Genet. 2012 Apr 15;44(5):552-61
pubmed: 22504417
Am J Psychiatry. 2020 Jul 1;177(7):589-600
pubmed: 32046535
Mol Psychiatry. 2016 Jun;21(6):806-12
pubmed: 26122586
Arch Gen Psychiatry. 2011 Mar;68(3):241-51
pubmed: 21383262
Am J Psychiatry. 2014 Aug;171(8):829-43
pubmed: 24626773
J Nerv Ment Dis. 2001 Jan;189(1):31-7
pubmed: 11206662
J Affect Disord. 2018 Jun;233:1-2
pubmed: 29395259
R Soc Open Sci. 2017 Feb 1;4(2):160254
pubmed: 28386409
Neuroimage. 2018 Nov 15;182:3-7
pubmed: 29024791
Biol Psychiatry. 2012 Mar 15;71(6):552-60
pubmed: 22281121
Bipolar Disord. 2016 Feb;18(1):4-18
pubmed: 26851067
Nat Genet. 2019 May;51(5):793-803
pubmed: 31043756
Aust N Z J Psychiatry. 2019 Dec;53(12):1179-1188
pubmed: 31244332
Neuroimage. 2013 Nov 1;81:455-469
pubmed: 23629049
Nat Rev Dis Primers. 2018 Mar 08;4:18008
pubmed: 29516993
Lancet. 2013 Apr 20;381(9875):1371-1379
pubmed: 23453885
Neuroimage. 2012 Jul 16;61(4):1000-16
pubmed: 22484410
JAMA Psychiatry. 2018 Nov 1;75(11):1146-1155
pubmed: 30304337
Biol Psychiatry. 2019 Oct 1;86(7):499-501
pubmed: 31521208
Soc Psychiatry Psychiatr Epidemiol. 2013 Oct;48(10):1601-10
pubmed: 23754681
JAMA Psychiatry. 2019 Apr 1;76(4):353-354
pubmed: 30810720
Psychother Psychosom. 2019;88(3):171-176
pubmed: 30955011
J Am Acad Child Adolesc Psychiatry. 2005 Jun;44(6):565-73
pubmed: 15908839
Neuropsychopharmacology. 2014 Nov;39(12):2910-8
pubmed: 25074491
J Affect Disord. 2016 May;195:148-55
pubmed: 26896807
Brain. 2018 Feb 1;141(2):391-408
pubmed: 29365066
Psychol Med. 2014 Feb;44(3):507-17
pubmed: 23721695
Bipolar Disord. 2017 Mar;19(2):74-83
pubmed: 28444949
Annu Rev Clin Psychol. 2015;11:251-81
pubmed: 25581236
Neuroimage. 2016 Jul 15;135:177-85
pubmed: 27153982
Biol Psychiatry. 2000 Jul 15;48(2):147-62
pubmed: 10903411
Am J Psychiatry. 2014 Apr;171(4):395-7
pubmed: 24687194
PLoS Genet. 2020 May 19;16(5):e1008612
pubmed: 32427991
Mol Psychiatry. 2016 Dec;21(12):1710-1716
pubmed: 26857596
Hum Brain Mapp. 2022 Jan;43(1):385-398
pubmed: 33073925
Biol Psychiatry. 2010 Jul 1;68(1):41-50
pubmed: 20609836
Am J Psychiatry. 2018 Apr 1;175(4):359-369
pubmed: 29145754
Nature. 2015 Apr 9;520(7546):224-9
pubmed: 25607358
Nat Neurosci. 2016 Dec;19(12):1569-1582
pubmed: 27694991
Neuropsychopharmacology. 2019 Dec;44(13):2285-2293
pubmed: 31434102
Neuron. 2002 Jan 31;33(3):341-55
pubmed: 11832223
Mol Psychiatry. 2020 Apr;25(4):883-895
pubmed: 31780770
Lancet Psychiatry. 2016 Feb;3(2):171-8
pubmed: 26851330
Psychiatry Res. 2010 Jun 30;182(3):207-10
pubmed: 20493671
JAMA Psychiatry. 2014 Apr;71(4):388-96
pubmed: 24522197
Lancet. 2000 Oct 7;356(9237):1241-2
pubmed: 11072948
Cell. 2018 Jun 14;173(7):1705-1715.e16
pubmed: 29906448
Am J Psychiatry. 2019 Feb 1;176(2):119-128
pubmed: 30336705
Neuropsychopharmacology. 2010 Jul;35(8):1743-50
pubmed: 20357761
Mol Psychiatry. 2020 Nov;25(11):2818-2831
pubmed: 31358905
Mol Psychiatry. 2020 Aug;25(8):1822-1834
pubmed: 29895892
Prog Neuropsychopharmacol Biol Psychiatry. 2015 Jul 3;60:1-10
pubmed: 25661850
Schizophr Bull. 1976;2(3):360-401
pubmed: 1034336
Biol Psychiatry. 2018 Nov 1;84(9):644-654
pubmed: 29960671
Schizophr Bull. 2007 Jul;33(4):886-92
pubmed: 17562693
Mol Psychiatry. 2015 May;20(5):555-62
pubmed: 25754081
Transl Psychiatry. 2020 Mar 20;10(1):100
pubmed: 32198361
Biol Psychiatry. 2008 Oct 15;64(8):730-733
pubmed: 18620337
Int Rev Psychiatry. 2005 Feb;17(1):9-19
pubmed: 16194767
Hum Brain Mapp. 2017 Aug;38(8):3757-3770
pubmed: 28480992
Hum Brain Mapp. 2018 Nov;39(11):4183-4195
pubmed: 29947131

Auteurs

Christopher R K Ching (CRK)

Imaging Genetics Center, Mark and Mary Stevens Neuroimaging and Informatics Institute, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.

Derrek P Hibar (DP)

Genentech, Inc., South San Francisco, California, USA.

Tiril P Gurholt (TP)

Norwegian Centre for Mental Disorders Research (NORMENT), Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Division of Mental Health and Addicition, Oslo University Hospital, Oslo, Norway.

Abraham Nunes (A)

Department of Psychiatry, Dalhousie University, Halifax, Nova Scotia, Canada.
Faculty of Computer Science, Dalhousie University, Halifax, Nova Scotia, Canada.

Sophia I Thomopoulos (SI)

Imaging Genetics Center, Mark and Mary Stevens Neuroimaging and Informatics Institute, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.

Christoph Abé (C)

Faculty of Computer Science, Dalhousie University, Halifax, Nova Scotia, Canada.
Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.

Ingrid Agartz (I)

Norwegian Centre for Mental Disorders Research (NORMENT), Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Department of Psychiatric Research, Diakonhjemmet Hospital, Oslo, Norway.
Center for Psychiatric Research, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.

Rachel M Brouwer (RM)

Department of Psychiatry, University Medical Center Utrecht Brain Center, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.

Dara M Cannon (DM)

Centre for Neuroimaging & Cognitive Genomics (NICOG), Clinical Neuroimaging Laboratory, NCBES Galway Neuroscience Centre, College of Medicine Nursing and Health Sciences, National University of Ireland Galway, Galway, Ireland.

Sonja M C de Zwarte (SMC)

Department of Psychiatry, University Medical Center Utrecht Brain Center, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.

Lisa T Eyler (LT)

Department of Psychiatry, University of California, La Jolla, California, USA.
Desert-Pacific MIRECC, VA San Diego Healthcare, San Diego, California, USA.

Pauline Favre (P)

INSERM U955, team 15 "Translational Neuro-Psychiatry", Créteil, France.
Neurospin, CEA Paris-Saclay, team UNIACT, Gif-sur-Yvette, France.

Tomas Hajek (T)

Division of Mental Health and Addicition, Oslo University Hospital, Oslo, Norway.
National Institute of Mental Health, Klecany, Czech Republic.

Unn K Haukvik (UK)

Division of Mental Health and Addicition, Oslo University Hospital, Oslo, Norway.
Norwegian Centre for Mental Disorders Research (NORMENT), Oslo University Hospital, Oslo, Norway.

Josselin Houenou (J)

INSERM U955, team 15 "Translational Neuro-Psychiatry", Créteil, France.
Neurospin, CEA Paris-Saclay, team UNIACT, Gif-sur-Yvette, France.
APHP, Mondor University Hospitals, DMU IMPACT, Créteil, France.

Mikael Landén (M)

Department of Neuroscience and Physiology, University of Gothenburg, Gothenburg, Sweden.
Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.

Tristram A Lett (TA)

Department for Psychiatry and Psychotherapy, Charité Universitätsmedizin Berlin, Berlin, Germany.
Department of Neurology with Experimental Neurology, Charité Universitätsmedizin Berlin, Berlin, Germany.

Colm McDonald (C)

Department of Psychiatry, University Medical Center Utrecht Brain Center, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.

Leila Nabulsi (L)

Imaging Genetics Center, Mark and Mary Stevens Neuroimaging and Informatics Institute, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.
Department of Psychiatry, University Medical Center Utrecht Brain Center, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.

Yash Patel (Y)

Bloorview Research Institute, Holland Bloorview Kids Rehabilitation Hospital, Toronto, Ontario, Canada.

Melissa E Pauling (ME)

Desert-Pacific MIRECC, VA San Diego Healthcare, San Diego, California, USA.
INSERM U955, team 15 "Translational Neuro-Psychiatry", Créteil, France.

Tomas Paus (T)

Bloorview Research Institute, Holland Bloorview Kids Rehabilitation Hospital, Toronto, Ontario, Canada.
Departments of Psychology and Psychiatry, University of Toronto, Toronto, Ontario, Canada.

Joaquim Radua (J)

Department of Psychiatric Research, Diakonhjemmet Hospital, Oslo, Norway.
Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Barcelona, Spain.
Early Psychosis: Interventions and Clinical-detection (EPIC) lab, Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
Stockholm Health Care Services, Stockholm County Council, Stockholm, Sweden.

Marcio G Soeiro-de-Souza (MG)

Mood Disorders Unit (GRUDA), Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de São Paulo, São Paulo, SP, Brazil.

Giulia Tronchin (G)

Department of Psychiatry, University Medical Center Utrecht Brain Center, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.

Neeltje E M van Haren (NEM)

Department of Child and Adolescent Psychiatry/Psychology, Erasmus Medical Center, Rotterdam, The Netherlands.

Eduard Vieta (E)

Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Barcelona, Spain.
Barcelona Bipolar Disorders and Depressive Unit, Hospital Clinic, Institute of Neurosciences, University of Barcelona, Barcelona, Spain.

Henrik Walter (H)

Department for Psychiatry and Psychotherapy, Charité Universitätsmedizin Berlin, Berlin, Germany.

Ling-Li Zeng (LL)

Imaging Genetics Center, Mark and Mary Stevens Neuroimaging and Informatics Institute, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.
College of Intelligence Science and Technology, National University of Defense Technology, Changsha, China.

Martin Alda (M)

Division of Mental Health and Addicition, Oslo University Hospital, Oslo, Norway.

Jorge Almeida (J)

Dell Medical School, The University of Texas at Austin, Austin, Texas, USA.

Dag Alnaes (D)

Norwegian Centre for Mental Disorders Research (NORMENT), Institute of Clinical Medicine, University of Oslo, Oslo, Norway.

Silvia Alonso-Lana (S)

FIDMAG Germanes Hospitalàries Research Foundation, Barcelona, Spain.
CIBERSAM, Madrid, Spain.

Cara Altimus (C)

Milken Institute Center for Strategic Philanthropy, Washington, District of Columbia, USA.

Michael Bauer (M)

Department of Psychiatry and Psychotherapy, Medical Faculty, Technische Universität Dresden, Dresden, Germany.

Bernhard T Baune (BT)

Department of Psychiatry, University of Münster, Münster, Germany.
Department of Psychiatry, The University of Melbourne, Melbourne, Victoria, Australia.
The Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Melbourne, Victoria, Australia.

Carrie E Bearden (CE)

Department of Psychiatry and Biobehavioral Sciences, Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles, California, USA.
Department of Psychology, University of California, Los Angeles, California, USA.

Marcella Bellani (M)

Section of Psychiatry, Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Verona, Italy.

Francesco Benedetti (F)

Vita-Salute San Raffaele University, Milan, Italy.
Division of Neuroscience, Psychiatry and Psychobiology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.

Michael Berk (M)

Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy.
IMPACT Institute - The Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Barwon Health, Deakin University, Geelong, Victoria, Australia.

Amy C Bilderbeck (AC)

The National Centre of Excellence in Youth Mental Health, Centre for Youth Mental Health, Florey Institute for Neuroscience and Mental Health and the Department of Psychiatry, The University of Melbourne, Orygen, Melbourne, Victoria, Australia.
P1vital Ltd, Wallingford, UK.

Hilary P Blumberg (HP)

Department of Psychiatry, University of Oxford, Oxford, UK.

Erlend Bøen (E)

Mood Disorders Research Program, Yale School of Medicine, New Haven, Connecticut, USA.

Irene Bollettini (I)

Division of Neuroscience, Psychiatry and Psychobiology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.

Caterina Del Mar Bonnin (C)

Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Barcelona, Spain.
Barcelona Bipolar Disorders and Depressive Unit, Hospital Clinic, Institute of Neurosciences, University of Barcelona, Barcelona, Spain.

Paolo Brambilla (P)

Psychosomatic and CL Psychiatry, Oslo University Hospital, Oslo, Norway.
Department of Neurosciences and Mental Health, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.

Erick J Canales-Rodríguez (EJ)

FIDMAG Germanes Hospitalàries Research Foundation, Barcelona, Spain.
CIBERSAM, Madrid, Spain.
Department of Radiology, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland.
Signal Processing Lab (LTS5), École Polytechnique Fédérale de Lausanne, Lausanne, Switzerland.

Xavier Caseras (X)

MRC Centre for Neuropsychiatric Genetics and Genomics, Cardiff University, Cardiff, UK.

Orwa Dandash (O)

Melbourne Neuropsychiatry Centre, Department of Psychiatry, University of Melbourne and Melbourne Health, Melbourne, Victoria, Australia.
Brain, Mind and Society Research Hub, Turner Institute for Brain and Mental Health, School of Psychological Sciences, Monash University, Clayton, Victoria, Australia.

Udo Dannlowski (U)

Department of Psychiatry, University of Münster, Münster, Germany.

Giuseppe Delvecchio (G)

Psychosomatic and CL Psychiatry, Oslo University Hospital, Oslo, Norway.

Ana M Díaz-Zuluaga (AM)

Research Group in Psychiatry GIPSI, Department of Psychiatry, Faculty of Medicine, Universidad de Antioquia, Medellín, Colombia.

Danai Dima (D)

Department of Psychology, School of Social Sciences and Arts, City, University of London, London, UK.
Department of Neuroimaging, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.

Édouard Duchesnay (É)

INSERM U955, team 15 "Translational Neuro-Psychiatry", Créteil, France.

Torbjørn Elvsåshagen (T)

Norwegian Centre for Mental Disorders Research (NORMENT), Oslo University Hospital, Oslo, Norway.
Department of Neurology, Oslo University Hospital, Oslo, Norway.
Institute of Clinical Medicine, University of Oslo, Oslo, Norway.

Scott C Fears (SC)

Center for Neurobehavioral Genetics, Los Angeles, California, USA.
Greater Los Angeles Veterans Administration, Los Angeles, California, USA.

Sophia Frangou (S)

Centre for Brain Health, University of British Columbia, Vancouver, British Columbia, Canada.
Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, New York, USA.

Janice M Fullerton (JM)

Neuroscience Research Australia, Randwick, New South Wales, Australia.
School of Medical Sciences, University of New South Wales, Sydney, New South Wales, Australia.

David C Glahn (DC)

Department of Psychiatry, Boston Children's Hospital and Harvard Medical School, Boston, Massachusetts, USA.

Jose M Goikolea (JM)

Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Barcelona, Spain.
Barcelona Bipolar Disorders and Depressive Unit, Hospital Clinic, Institute of Neurosciences, University of Barcelona, Barcelona, Spain.

Melissa J Green (MJ)

Neuroscience Research Australia, Randwick, New South Wales, Australia.
School of Psychiatry, University of New South Wales, Sydney, New South Wales, Australia.

Dominik Grotegerd (D)

Department of Psychiatry, University of Münster, Münster, Germany.

Oliver Gruber (O)

Department of General Psychiatry, Heidelberg University, Heidelberg, Germany.

Bartholomeus C M Haarman (BCM)

Department of Psychiatry, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.

Chantal Henry (C)

Department of Psychiatry, Service Hospitalo-Universitaire, GHU Paris Psychiatrie & Neurosciences, Paris, France.
Université de Paris, Paris, France.

Fleur M Howells (FM)

Neuroscience Institute, University of Cape Town, Cape Town, South Africa.
Department of Psychiatry and Mental Health, University of Cape Town, Cape Town, South Africa.

Victoria Ives-Deliperi (V)

Neuroscience Institute, University of Cape Town, Cape Town, South Africa.

Andreas Jansen (A)

Core-Facility Brainimaging, Faculty of Medicine, University of Marburg, Marburg, Germany.
Department of Psychiatry and Psychotherapy, Philipps-University Marburg, Marburg, Germany.

Tilo T J Kircher (TTJ)

Department of Psychiatry and Psychotherapy, Philipps-University Marburg, Marburg, Germany.

Christian Knöchel (C)

Department of Psychiatry, Psychosomatic Medicine and Psychotherapy, Goethe University Frankfurt, Frankfurt, Germany.

Bernd Kramer (B)

Department of General Psychiatry, Heidelberg University, Heidelberg, Germany.

Beny Lafer (B)

Laboratory of Psychiatric Neuroimaging (LIM-21), Departamento e Instituto de Psiquiatria, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de São Paulo, São Paulo, SP, Brazil.

Carlos López-Jaramillo (C)

Research Group in Psychiatry GIPSI, Department of Psychiatry, Faculty of Medicine, Universidad de Antioquia, Medellín, Colombia.
Mood Disorders Program, Hospital Universitario Trastorno del Ánimo, Medellín, Colombia.

Rodrigo Machado-Vieira (R)

Experimental Therapeutics and Molecular Pathophysiology Program, Department of Psychiatry, UTHealth, University of Texas, Houston, Texas, USA.

Bradley J MacIntosh (BJ)

Hurvitz Brain Sciences, Sunnybrook Research Institute, Toronto, Ontario, Canada.
Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada.

Elisa M T Melloni (EMT)

Vita-Salute San Raffaele University, Milan, Italy.
Division of Neuroscience, Psychiatry and Psychobiology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.

Philip B Mitchell (PB)

School of Psychiatry, University of New South Wales, Sydney, New South Wales, Australia.

Igor Nenadic (I)

Department of Psychiatry and Psychotherapy, Philipps-University Marburg, Marburg, Germany.

Fabiano Nery (F)

University of Cincinnati, Cincinnati, Ohio, USA.
Universidade de São Paulo, São Paulo, SP, Brazil.

Allison C Nugent (AC)

MEG Core Facility, Bethesda, Maryland, USA.

Viola Oertel (V)

Department of Psychiatry, Psychosomatic Medicine and Psychotherapy, Goethe University Frankfurt, Frankfurt, Germany.

Roel A Ophoff (RA)

UCLA Center for Neurobehavioral Genetics, Los Angeles, California, USA.
Department of Psychiatry, Erasmus Medical Center, Erasmus University, Rotterdam, The Netherlands.

Miho Ota (M)

Department of Mental Disorder Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Tokyo, Japan.

Bronwyn J Overs (BJ)

Neuroscience Research Australia, Randwick, New South Wales, Australia.

Daniel L Pham (DL)

Milken Institute Center for Strategic Philanthropy, Washington, District of Columbia, USA.

Mary L Phillips (ML)

Department of Psychiatry, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.

Julian A Pineda-Zapata (JA)

Research Group, Instituto de Alta Tecnología Médica (IATM), Medellín, Colombia.

Sara Poletti (S)

Vita-Salute San Raffaele University, Milan, Italy.
Division of Neuroscience, Psychiatry and Psychobiology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.

Mircea Polosan (M)

University of Grenoble Alpes, CHU Grenoble Alpes, Grenoble, France.
INSERM U1216 - Grenoble Institut des Neurosciences, La Tronche, France.

Edith Pomarol-Clotet (E)

FIDMAG Germanes Hospitalàries Research Foundation, Barcelona, Spain.
CIBERSAM, Madrid, Spain.

Arnaud Pouchon (A)

University of Grenoble Alpes, CHU Grenoble Alpes, Grenoble, France.

Yann Quidé (Y)

Neuroscience Research Australia, Randwick, New South Wales, Australia.
School of Psychiatry, University of New South Wales, Sydney, New South Wales, Australia.

Maria M Rive (MM)

Department of Psychiatry, Amsterdam UMC, location AMC, Amsterdam, The Netherlands.

Gloria Roberts (G)

School of Psychiatry, University of New South Wales, Sydney, New South Wales, Australia.

Henricus G Ruhe (HG)

Department of Psychiatry, Radboud University Medical Center, Nijmegen, The Netherlands.
Donders Institute for Brain, Cognition and Behavior, Radboud University, Nijmegen, The Netherlands.

Raymond Salvador (R)

FIDMAG Germanes Hospitalàries Research Foundation, Barcelona, Spain.
CIBERSAM, Madrid, Spain.

Salvador Sarró (S)

FIDMAG Germanes Hospitalàries Research Foundation, Barcelona, Spain.
CIBERSAM, Madrid, Spain.

Theodore D Satterthwaite (TD)

Department of Psychiatry, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.

Aart H Schene (AH)

Department of Psychiatry, Radboud University Medical Center, Nijmegen, The Netherlands.

Kang Sim (K)

West Region, Institute of Mental Health, Singapore, Singapore.
Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.

Jair C Soares (JC)

Center of Excellent on Mood Disorders, UTHealth Houston, Houston, Texas, USA.
Department of Psychiatry and Behavioral Sciences, UTHealth Houston, Houston, Texas, USA.

Michael Stäblein (M)

Department of Psychiatry, Psychosomatic Medicine and Psychotherapy, Goethe University Frankfurt, Frankfurt, Germany.

Dan J Stein (DJ)

Neuroscience Institute, University of Cape Town, Cape Town, South Africa.
Department of Psychiatry and Mental Health, University of Cape Town, Cape Town, South Africa.
SAMRC Unit on Risk & Resilience in Mental Disorders, University of Cape Town, Cape Town, South Africa.

Christian K Tamnes (CK)

Norwegian Centre for Mental Disorders Research (NORMENT), Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Department of Psychiatric Research, Diakonhjemmet Hospital, Oslo, Norway.
PROMENTA Research Center, Department of Psychology, University of Oslo, Oslo, Norway.

Georgios V Thomaidis (GV)

Papanikolaou General Hospital, Thessaloniki, Greece.
Laboratory of Mechanics and Materials, School of Engineering, Aristotle University, Thessaloniki, Greece.

Cristian Vargas Upegui (CV)

Research Group in Psychiatry GIPSI, Department of Psychiatry, Faculty of Medicine, Universidad de Antioquia, Medellín, Colombia.

Dick J Veltman (DJ)

Department of Psychiatry, Amsterdam UMC, Amsterdam, The Netherlands.

Michèle Wessa (M)

Department of Neuropsychology and Clinical Psychology, Johannes Gutenberg-University Mainz, Mainz, Germany.

Lars T Westlye (LT)

Department of Psychology, University of Oslo, Oslo, Norway.
Norwegian Centre for Mental Disorders Research (NORMENT), Department of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway.

Heather C Whalley (HC)

Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK.

Daniel H Wolf (DH)

Department of Psychiatry, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.

Mon-Ju Wu (MJ)

Department of Psychiatry and Behavioral Sciences, UTHealth Houston, Houston, Texas, USA.

Lakshmi N Yatham (LN)

Department of Psychiatry, University of British Columbia, Vancouver, British Columbia, Canada.

Carlos A Zarate (CA)

Chief Experimental Therapeutics & Pathophysiology Branch, Bethesda, Maryland, USA.
Intramural Research Program, National Institute of Mental Health, Bethesda, Maryland, USA.

Paul M Thompson (PM)

Imaging Genetics Center, Mark and Mary Stevens Neuroimaging and Informatics Institute, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.

Ole A Andreassen (OA)

Norwegian Centre for Mental Disorders Research (NORMENT), Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Division of Mental Health and Addicition, Oslo University Hospital, Oslo, Norway.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH